Literature DB >> 20451866

Strabismus surgery on the elderly and the effects on disability.

Kevin Merrill1, Denise Satterfield, Mary O'Hara.   

Abstract

It is widely believed that strabismus surgery in elderly adults has low value and is of limited benefit. In this study, consecutive patients older than 65 years of age who had undergone strabismus surgery were asked to complete a telephone questionnaire rating their before-surgery and after-surgery severity of various problems, including specific health, daily functioning, social interactions, concerns about the future, self-image, and job-related problems. Of the 56 patients identified, 37 completed the survey. Problem ratings improved significantly on all 5 of 6 items after surgery, with specific health and daily tasks yielding the greatest improvement. For all items, the number of patients who indicated an improvement was greater than the number of patients who indicated no change or deterioration with surgery. This study further details the benefits of strabismus surgery in the elderly. Copyright 2010 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20451866     DOI: 10.1016/j.jaapos.2009.12.282

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  3 in total

1.  Improved ocular alignment with adjustable sutures in adults undergoing strabismus surgery.

Authors:  Monica S Zhang; Amy K Hutchinson; Arlene V Drack; Julia Cleveland; Scott R Lambert
Journal:  Ophthalmology       Date:  2011-10-29       Impact factor: 12.079

2.  A survey of outcome of adjustable suture as first operation in patients with strabismus.

Authors:  Hasan Razmjoo; Hosein Attarzadeh; Najmeh Karbasi; Mohammad Reza Najarzadegan; Hasan Salam; Aliraza Jamshidi
Journal:  Adv Biomed Res       Date:  2014-08-26

3.  Driving Skills Tested on Simulator After Strabismus Surgery: A Prospective Study.

Authors:  Dan Derhy; Ségolène Lithfous; Claude Speeg; David Gaucher; Olivier Despres; André Dufour; Tristan Bourcier; Arnaud Sauer
Journal:  Transl Vis Sci Technol       Date:  2020-07-24       Impact factor: 3.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.